Compare FMC Corp (FMC) vs Progressive Corp (PGR) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Progressive (PGR) trades at $203.56, down 10.16% over 24 hours, reflecting bearish technical signals and recent earnings misses. The stock shows strong fundamentals with a P/E of 10.3, net income margin of 12.93%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Analyst consensus is mixed with a $238.56 price target, while recent news highlights Q2 2026 earnings beating estimates but facing profit decline concerns.

The outlook balances solid profitability and valuation appeal against technical weakness and earnings volatility. Key opportunities include attractive multiples and operational strength, while risks involve competitive pressures and market sentiment shifts. Investors should weigh fundamental resilience against near-term price pressure.